Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-8-18
pubmed:abstractText
The chemokine stromal cell-derived factor-1alpha (SDF-1alpha) binds to the chemokine receptor CXCR4 that couples to pertussis toxin-sensitive G-proteins of the G(i)/G(o)-family. CXCR4 plays a role in the pathogenesis of autoimmune diseases, human immunodeficiency virus infection and various tumors, fetal development as well as endothelial progenitor and T-cell recruitment. To this end, most CXCR4 studies have focused on the cellular level. The aim of this study was to establish a reconstitution system for the human CXCR4 that allows for the analysis of receptor/G-protein coupling at the membrane level. We wished to study specifically constitutive CXCR4 activity and the G-protein-specificity of CXCR4. We co-expressed N- and C-terminally epitope-tagged human CXCR4 with various G(i)/G(o)-proteins and regulator of G-protein signaling (RGS)-proteins in Sf9 insect cells. Expression of CXCR4, G-proteins, and RGS-proteins was verified by immunoblotting. CXCR4 coupled more effectively to Galpha(i1) and Galpha(i2) than to Galpha(i3) and Galpha(o) and insect cell G-proteins as assessed by SDF-1alpha-stimulated high-affinity steady-state GTP hydrolysis. The RGS-proteins RGS4 and GAIP enhanced SDF-1alpha-stimulated GTP hydrolysis. SDF-1alpha stimulated [(35)S]guanosine 5'-[gamma-thio]triphosphate (GTPgammaS) binding to Galpha(i2). RGS4 did not enhance GTPgammaS binding. Na(+) salts of halides did not reduce basal GTPase activity. The bicyclam, 1-[[1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane (AMD3100), acted as CXCR4 antagonist but was devoid of inverse agonistic activity. Halides reduced the maximum SDF-1alpha-stimulated GTP hydrolysis in the order of efficacy I(-) > Br(-) > Cl(-). In addition, salts reduced the potency of SDF-1alpha at activating GTP hydrolysis. From our data, we conclude the following: (1) Sf9 cells are a suitable system for expression of functionally intact human CXCR4; (2) Human CXCR4 couples effectively to Galpha(i1) and Galpha(i2); (3) There is no evidence for constitutive activity of CXCR4; (4) RGS-proteins enhance agonist-stimulated GTP hydrolysis, showing that GTP hydrolysis becomes rate-limiting in the presence of SDF-1alpha; (5) By analogy to previous observations made for the beta(2)-adrenoceptor coupled to G(s), the inhibitory effects of halides on agonist-stimulated GTP hydrolysis may be due to increased GDP-affinity of G(i)-proteins, reducing the efficacy of CXCR4 at stimulating nucleotide exchange.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-10486146, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-10559200, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-10620340, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-10966476, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-11040042, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-11069075, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-11154697, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-11454950, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-11456467, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-11470148, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-11697079, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-11841575, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-11923301, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-12037138, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-12171912, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-14585837, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-15250496, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-15339043, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-15632118, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-16930987, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-16943240, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-16958560, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-17017998, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-17169327, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-17258171, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-1730649, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-17339399, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-1851930, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-1903107, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-2156152, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-2160274, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-2502402, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-2515070, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-2820999, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-3102490, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-35231, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-4202581, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-9295051, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-9463473, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-9716378, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-9722546, http://linkedlifedata.com/resource/pubmed/commentcorrection/18523757-9727041
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0028-1298
pubmed:author
pubmed:issnType
Print
pubmed:volume
378
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
261-74
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Functional reconstitution of the human chemokine receptor CXCR4 with G(i)/G (o)-proteins in Sf9 insect cells.
pubmed:affiliation
Lehrstuhl für Pharmakologie und Toxikologie, Institut für Pharmazie, Universität Regensburg, Regensburg, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural